NCT03176979View on ClinicalTrials.gov

Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

April 21, 2017

Primary Completion Date

July 8, 2021

Study Completion Date

July 8, 2021

Conditions
Breast Carcinoma
Interventions
OTHER

Contrast Agent

Given IV

PROCEDURE

Digital Tomosynthesis Mammography

Undergo CESM with DBT

PROCEDURE

Dual-Energy Contrast-Enhanced Digital Spectral Mammography

Undergo CESM with DBT

Trial Locations (1)

90033

USC / Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Southern California

OTHER

NCT03176979 - Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer | Biotech Hunter | Biotech Hunter